BRKR
Bruker Corporation
NASDAQ · USHealthcareMedical - Devices
$56.17-3.54%
Price as of Jul 20, 2026
BRKR valuation
Bruker Corporation valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 23.82x
- P/E 2026E
- 26.75x
- P/E 2027E
- 23.37x
- P/E 2028E
- 20.47x
- P/S forward
- 2.38x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.55x
- Price / sales
- 2.52x
- Price / cash flow
- 62.05x
Enterprise value
- Enterprise value
- $10.3B
- EV / sales
- 2.98x
- EV / EBITDA
- 34.02x
- EV / EBIT
- 50.55x
- Market cap
- $8.7B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.